BioNewslink
The Newsletter of BioStrategy Partners

In This Issue

From the Executive Director

Practical Knowledge Series: Upcoming Programs

Protecting Your Assets in the Electronic Workplace

News from Our Community

Thank you to our sponsors.

Founded in 2004, BioStrategy Partners is a virtual incubator providing technology and business development services to emerging-stage life sciences companies and university-based research projects in the Greater Philadelphia region. BioSP specializes in offering business guidance and support to first-time entrepreneurs, scientific founders, and university-based principal investigators. For more information, please visit our web site, http://www.biostrategypartners.org.

March, 2009

From the Executive Director

Karen J. Hanson, Ph.D.

BioStrategy Partners, in partnership with Montgomery County Community College and Bucks County Community College, has been awarded an Innovation Investment Grant of $124,400 from the Delaware Valley Innovation Network (DVIN). DVIN is a tri-state partnership formed under the U.S. Department of Labor's Workforce Innovation in Regional Economic Development (WIRED) initiative, and Innovation Investment Grants are designed to enhance proven and new programs and be a catalyst to educate, train and develop talent for the region's life science industry.

BioSP's grant is for our Life Sciences Leadership Forum, a series of monthly skill-building and networking sessions designed to boost the business skills of scientific founders and network them into the broader life sciences community, thus improving their chances of reaching the next level of commercialization. Through this grant, BioSP will offer Forums in southeastern Pennsylvania, northern Delaware in partnership with Delaware Tech and Delaware BIO, and in South Jersey in partnership with Burlington County College, Bio NJ, and NJEDA. For more information, please email us at info@biostrategypartners.org.info@biostrategypartners.org.

Practical Knowledge Series: Upcoming Programs
SAVE THE DATE! Thursday, May 14, 2009 8:30AM - 11:00AM Clinical Trials: Managing Expectations While Managing Budgets Lankenau Institute for Medical Research The Walter and Lenore Annenberg Conference Center Annenberg Room 101A 190 Lancaster Avenue Wynnewood, PA 19096

Protecting Your Assets in the Electronic Workplace

By Catherine E. Walters, Esquire

Saul Ewing LLP

Whether your business is emerging or established, virtually every business has employees. They can be among your most valuable resources but, depending on their activities, they can also be among your most expensive resources. Despite your investment in them, employees leave, requiring you to reinvest in their replacements. Despite your efforts to protect your property and your business, former employees compete with you, using your developments, soliciting your clients, and in some cases, luring more of your employees to leave. And despite well-drafted and well-communicated policies, current employees may infringe upon the rights of others in numerous ways, bringing unwanted liabilities to you.

Today's workplace is an electronic workplace, where communication and collaboration occur in a multitude of ways and where intellectual property and other confidential and proprietary information can be transmitted in an instant. While workplace efficiency has been enhanced through use of numerous electronic tools and ready access to information, the number of lawsuits and other challenges flowing from use of technology have escalated. Some of these challenges include defamation, harassment, employee privacy concerns, identity theft, sabotage, and misuse or theft of trade secrets, intellectual property and other confidential or proprietary information. This article will focus on protecting trade secrets, confidential information and intellectual property.

News From Our Community

Creative Footwear Technology, a KIZ company headed by Richard Posoff, has signed an exclusive license for technology developed with podiatrists James McGuire and Kendrick Whitney at Temple University's School of Podiatric Medicine. This photo was taken at the signing ceremony.

Inteprod, a medical product design, development, and contract manufacturer located in the Valley Forge Corporate Center, has immediate openings for Mechanical, Electrical, and Software engineers with medical device experience. Qualified applicants interested in joining a growing and successful company may submit resumes to inteprodcareers@inteprod.com.

Drug Detection Solutions, LLC, a KIZ company, is a subcontractor to the State Department's International Narcotics and Law Enforcement Agency's efforts to curb the growing of opium in Afghanistan. Using its technology to detect opium on surfaces and in the air, DDS has managed a project in 2008 and testing the homes and residents in opium growing areas of Afghanistan. It has long been known that Afghanistan produces the majority of the world's opium and heroin, but little is known about the extent of opium addiction within the Afghanistan population. DDS's President and Chief Executive Officer, Dr. David Martin says, "The results of our study are striking and will be presented at the College on Problems of Drug Dependence meetings on June 22, 2009. We tested 30 homes and over 150 surface samples and children as young as 11 months old." Dr. Martin will be travelling to Kabul in July to train medical doctors and members of the Afghanistan Ministry of Counter Narcotics on the use of DDS technologies which are designed not only to detect drugs of abuse on surfaces, but explosives, weapons of mass destruction, food toxins and industrial wastes. For more information on DDS contact David M. Martin, Ph.D.Chief Executive Officer and President Drug Detection Solutions, phone 215.527.9528 email david.martin@drug-detection-solutions.com.

BioLeap LLC, a global leader in predictive drug discovery, is pleased to announce that Andrew K. W. Powell, Esq. has joined BioLeap's Board of Directors.

Andrew is broadly recognized in the pharmaceutical industry as a senior executive with extensive experience in corporate governance and in structuring and implementing significant merger/acquisition events. "BioLeap is fortunate to have Andrew's active involvement as we continue to grow the company. His broad industry experience coupled with his deep expertise in the areas of structuring collaborations, investments and M&A activities will prove invaluable", commented David Pompliano, CEO of BioLeap. "I am excited to be assuming this important role as Bioleap prepares to enhance its service offerings and advance its development programs" said Powell. Read More

Prescient Medical, Inc. reached a crucial milestone in February by completing the enrollment of 30 patients in the first phase of its first-in-human clinical trial for the vProtect™ Luminal Shield, conducted at the Corbic Research Institute in Colombia. The Shield successfully crossed all target lesions and was safely implanted in all 30 patients, with a technical success rate of 100%. No procedural or in-hospital complications were reported for any of the patients. The patients enrolled in the study had non-calcified lesions in coronary arteries, lesions that would normally be treated with traditional balloon-expandable stents. Read More

THIS IS A TEST EMAIL ONLY.
This email was sent by the author for the sole purpose of testing a draft message. If you believe you have received the message in error, please contact the author by replying to this message. Constant Contact takes reports of abuse very seriously: if you wish to report abuse, please forward this message to abuse@constantcontact.com.